| Issue |
Title |
File |
| Vol 11, No 3 (2011) |
BRAF as a Target for Cancer Therapy |
(Eng)
|
|
Dienstmann R., Tabernero J.
|
| Vol 11, No 3 (2011) |
Cytotoxic Effect of the Red Beetroot (Beta vulgaris L.) Extract Compared to Doxorubicin (Adriamycin) in the Human Prostate (PC-3) and Breast (MCF-7) Cancer Cell Lines |
(Eng)
|
|
J. Kapadia G., A. Azuine M., Subba Rao G., Arai T., Iida A., Tokuda H.
|
| Vol 11, No 3 (2011) |
Chemical Properties and Mechanisms Determining the Anti-Cancer Action of Garlic-Derived Organic Sulfur Compounds |
(Eng)
|
|
Cerella C., Dicato M., Jacob C., Diederich M.
|
| Vol 11, No 3 (2011) |
Anti-Proliferative Activity of Synthetic Ajoene Analogues on Cancer Cell-Lines |
(Eng)
|
|
H. Kaschula C., Hunter R., T. Hassan H., Stellenboom N., Cotton J., Q. Zhai X., Iqbal Parker M.
|
| Vol 11, No 3 (2011) |
Modulation of Histone Acetylation by Garlic Sulfur Compounds |
(Eng)
|
|
Druesne-Pecollo N., Latino-Martel P.
|
| Vol 11, No 7 (2011) |
Nitroimidazoles as Anti-Tumor Agents |
(Eng)
|
|
Liu K., Zhu H.
|
| Vol 11, No 2 (2011) |
Editorial [Hot Topic: SOD Enzymes and Their Mimics in Cancer: Pro- vs Anti-Oxidative Mode of Action-Part I (Guest Editor: Ines Batinic-Haberle)] |
(Eng)
|
|
Batinic-Haberle I.
|
| Vol 11, No 9 (2011) |
Targeting Sphingosine-1-Phosphate in Hematologic Malignancies |
(Eng)
|
|
E. Stevenson C., Takabe K., Nagahashi M., Milstien S., Spiegel S.
|
| Vol 11, No 9 (2011) |
Sphingolipid Signaling and Hematopoietic Malignancies: To the Rheostat and Beyond |
(Eng)
|
|
C. Loh K., Baldwin D., D. Saba J.
|
| Vol 11, No 9 (2011) |
Editorial [Hot Topic: Therapeutic Targeting of the Sphingolipid “Biostat” in Hematologic Malignancies (Guest Editors: Thomas P. Loughran and Hong-Gang Wang)] |
(Eng)
|
|
P. Loughran T., Wang H.
|
| Vol 11, No 8 (2011) |
Update on Laser Photochemotherapy: An Alternative for Cancer Treatment |
(Eng)
|
|
B. Paiva M., Joo J., Abrahao M., Carlos Ribeiro J., Cervantes O., A. Sercarz J.
|
| Vol 11, No 8 (2011) |
Effect of Selenium-Saturated Bovine Lactoferrin (Se-bLF) on Antioxidant Enzyme Activities in Human Gut Epithelial Cells Under Oxidative Stress |
(Eng)
|
|
Burrow H., K. Kanwar R., Mahidhara G., R. Kanwar J.
|
| Vol 11, No 8 (2011) |
The Rationale of Targeting Neutrophils with Dapsone during Glioblastoma Treatment |
(Eng)
|
|
E. Kast R., Scheuerle A., R. Wirtz C., Karpel-Massler G., Halatsch M.
|
| Vol 11, No 8 (2011) |
Erlotinib in Glioblastoma - Lost in Translation? |
(Eng)
|
|
Karpel-Massler G., Andrew Westhoff M., E. Kast R., Rainer Wirtz C., Halatsch M.
|
| Vol 11, No 8 (2011) |
Clinical Development of Experimental Virus-Mediated Gene Therapy for Malignant Glioma |
(Eng)
|
|
G. Rainov N., Heidecke V.
|
| Vol 11, No 8 (2011) |
Targeted Toxins for Glioblastoma Multiforme: Pre-Clinical Studies and Clinical Implementation |
(Eng)
|
|
Candolfi M., M. Kroeger K., Xiong W., Liu C., Puntel M., Yagiz K., Ghulam Muhammad A., Mineharu Y., Foulad D., Wibowo M., Assi H., J. Baker G., R. Lowenstein P., G. Castro M.
|
| Vol 11, No 9 (2011) |
Regulation of Sphingosine Kinase in Hematological Malignancies and Other Cancers |
(Eng)
|
|
M. Pitson S., A. Powell J., S. Bonder C.
|
| Vol 11, No 9 (2011) |
Targeting Sphingosine-1-Phosphate Receptors in Cancer |
(Eng)
|
|
J. Watters R., Wang H., Sung S., P. Loughran T., Liu X.
|
| Vol 11, No 9 (2011) |
Ceramide-Based Therapeutics for the Treatment of Cancer |
(Eng)
|
|
M. Barth B., C. Cabot M., Kester M.
|
| Vol 11, No 9 (2011) |
Ceramide Transfer Protein and Cancer |
(Eng)
|
|
Scheffer L., Rao Raghavendra P., Ma J., K. Acharya J.
|
| Vol 11, No 9 (2011) |
Sphingolipid Metabolism and Drug Resistance in Hematological Malignancies |
(Eng)
|
|
Gouaze-Andersson V., C. Cabot M.
|
| Vol 11, No 9 (2011) |
The Gut-To-Breast Connection - Interdependence of Sterols and Sphingolipids in Multidrug Resistance and Breast Cancer Therapy |
(Eng)
|
|
Spassieva S., Bieberich E.
|
| Vol 11, No 9 (2011) |
Sphingolipid Metabolism and Leukemia: A Potential for Novel Therapeutic Approaches |
(Eng)
|
|
Ann Burns T., Luberto C.
|
| Vol 11, No 9 (2011) |
Hypoxia-Inducible Factors and Sphingosine 1-Phosphate Signaling |
(Eng)
|
|
Cuvillier O., Ader I.
|
| Vol 11, No 9 (2011) |
Regulation of Autophagy by Sphingolipids |
(Eng)
|
|
Bedia C., Levade T., Codogno P.
|
| Vol 11, No 9 (2011) |
Ceramidases in Hematological Malignancies: Senseless or Neglected Target? |
(Eng)
|
|
Fabrias G., Bedia C., Casas J., Luis Abad J., Delgado A.
|
| Vol 11, No 9 (2011) |
S1P Regulation of Macrophage Functions in the Context of Cancer |
(Eng)
|
|
Weigert A., Weichand B., Brune B.
|
| Vol 11, No 8 (2011) |
Targeting βIII-Tubulin in Glioblastoma Multiforme: From Cell Biology and Histopathology to Cancer Therapeutics |
(Eng)
|
|
D. Katsetos C., Draber P., Kavallaris M.
|
| Vol 11, No 8 (2011) |
Angiogenesis in Glioblastoma Multiforme: Navigating the Maze |
(Eng)
|
|
G. Linkous A., M. Yazlovitskaya E.
|
| Vol 11, No 7 (2011) |
Focal Adhesion Kinase Controls Prostate Cancer Progression Via Intrinsic Kinase and Scaffolding Functions |
(Eng)
|
|
Figel S., H. Gelman I.
|
| Vol 11, No 7 (2011) |
FAK and WNT Signaling: The Meeting of Two Pathways in Cancer and Development |
(Eng)
|
|
Fonar Y., Frank D.
|
| Vol 11, No 7 (2011) |
Clinical Importance and Potential Use of Small Molecule Inhibitors of Focal Adhesion Kinase |
(Eng)
|
|
Schultze A., Fiedler W.
|
| Vol 11, No 7 (2011) |
Editorial [Hot topic: Focal Adhesion Kinase Signaling in Cancer- Part II (Guest Editor: Vita M. Golubovskaya)] |
(Eng)
|
|
M. Golubovskaya V.
|
| Vol 11, No 6 (2011) |
Hepatocellular Carcinoma Detection by Gallium Scan and Subsequent Treatment by Gallium Maltolate: Rationale and Case Study |
(Eng)
|
|
R. Bernstein L., J.M. van der Hoeven J., O. Boer R.
|
| Vol 11, No 6 (2011) |
Targeting Cell Death and Survival Receptors in Hepatocellular Carcinoma |
(Eng)
|
|
Muntane J.
|
| Vol 11, No 6 (2011) |
Targeting Receptor Tyrosine Kinase Pathways in Hepatocellular Carcinoma |
(Eng)
|
|
Wen Chong L., Anh Tuan Luu D., Tzen Jong C., Wei Ling Lam I., Huynh H., Wei Jie Ong R., Yi Qing Li P., Shean Lee S., Yang S.
|
| Vol 11, No 6 (2011) |
Points of Therapeutic Intervention Along the Wnt Signaling Pathway in Hepatocellular Carcinoma |
(Eng)
|
|
B. Nambotin S., R. Wands J., Kim M.
|
| Vol 11, No 6 (2011) |
Therapeutic Potential of Targeting Glypican-3 in Hepatocellular Carcinoma |
(Eng)
|
|
Allegretta M., Filmus J.
|
| Vol 11, No 7 (2011) |
FAK and p53 Protein Interactions |
(Eng)
|
|
M. Golubovskaya V., G. Cance W.
|
| Vol 11, No 7 (2011) |
Inhibition of Hyaluronan Synthase-3 Decreases Subcutaneous Colon Cancer Growth by Increasing Apoptosis |
(Eng)
|
|
P. Teng B., D. Heffler M., C. Lai E., Zhao Y., M. LeVea C., M. Golubovskaya V., M. BullardDunn K.
|
| Vol 11, No 8 (2011) |
Therapeutic Strategies to Target Multiple Kinases in Glioblastoma |
(Eng)
|
|
Sathornsumetee S.
|
| Vol 11, No 8 (2011) |
Nucleic Acid-Based Therapeutics for Glioblastoma |
(Eng)
|
|
Shir A., Levitzki A., Wagner E., Klein S., Ogris M.
|
| Vol 11, No 8 (2011) |
Editorial [Hot Topic: Targeted Therapy for Glioblastoma Multiforme (Guest Editor: Marc-Eric Halatsch)] |
(Eng)
|
|
Halatsch M.
|
| Vol 11, No 7 (2011) |
Nanoparticles in Oncology: The New Theragnostic Molecules |
(Eng)
|
|
Allegra A., Penna G., Alonci A., Rizzo V., Russo S., Musolino C.
|
| Vol 11, No 7 (2011) |
Recent Developments in the Mechanism of Anticancer Agents Based on Electron Transfer, Reactive Oxygen Species and Oxidative Stress |
(Eng)
|
|
Kovacic P., Somanathan R.
|
| Vol 11, No 7 (2011) |
Cell Contact/Adhesion Proteins Lgl and DFak56: Tumorigenic and Whole-Organism Vital Effects Studied in Drosophila |
(Eng)
|
|
Ya. Weisman N., D. Golubovsky M.
|
| Vol 11, No 7 (2011) |
Coordinated Expression of Pax-5 and FAK1 in Metastasis |
(Eng)
|
|
Crapoulet N., O'Brien P., J. Ouellette R., A. Robichaud G.
|
| Vol 11, No 7 (2011) |
Development of Focal Adhesion Kinase Inhibitors in Cancer Therapy |
(Eng)
|
|
Wee Ma W.
|
| Vol 11, No 7 (2011) |
A Novel Small Molecule Inhibitor of FAK and IGF-1R Protein Interactions Decreases Growth of Human Esophageal Carcinoma |
(Eng)
|
|
A. Ucar D., Cox A., He D., A. Ostrov D., Kurenova E., N. Hochwald S.
|
| Vol 11, No 6 (2011) |
Role of Class II Nuclear Receptors in Liver Carcinogenesis |
(Eng)
|
|
Li G., L. Guo G.
|
| Vol 11, No 1 (2011) |
Recent Advances in Protein Tyrosine Phosphatase Detection Using Chemical Probes |
(Eng)
|
|
Lee K., Jin Kang H., Xia Y., J. Chung S.
|
| Vol 11, No 1 (2011) |
PTPN13/PTPL1: An Important Regulator of Tumor Aggressiveness |
(Eng)
|
|
Freiss G., Chalbos D.
|
| Vol 11, No 1 (2011) |
SHP-1 in Cell-Cycle Regulation |
(Eng)
|
|
Lopez-Ruiz P., Rodriguez-Ubreva J., Ernesto Cariaga A., Alicia Cortes M., Colas B.
|
| Vol 11, No 1 (2011) |
PRL-3, An Emerging Marker of Carcinogenesis, Is Strongly Associated with Poor Prognosis |
(Eng)
|
|
Guzinska-Ustymowicz K., Pryczynicz A.
|
| Vol 11, No 1 (2011) |
In-Gel Protein Phosphatase Assays and Other Useful Methods for the Detection of Protein Phosphatase Activities |
(Eng)
|
|
Ishida A., Kameshita I.
|
| Vol 11, No 1 (2011) |
Protein Phosphatase 2A as a Potential Target for Anticancer Therapy |
(Eng)
|
|
Kalev P., A. Sablina A.
|
| Vol 11, No 1 (2011) |
Can We Effectively Degrade Microcystins? - Implications on Human Health |
(Eng)
|
|
A. de la Cruz A., G. Antoniou M., Hiskia A., Pelaez M., Song W., E. O'Shea K., He X., D. Dionysiou D.
|
| Vol 11, No 1 (2011) |
Tumor Promoters - Microcystin-LR, Nodularin and TNF-α and Human Cancer Development |
(Eng)
|
|
Fujiki H., Suganuma M.
|
| Vol 11, No 1 (2011) |
Editorial [Hot Topic: Rising of Phosphatases as Targets of Cancer Treatment (Guest Editor: Petr Heneberg)] |
(Eng)
|
|
Heneberg P.
|
| Vol 11, No 10 (2011) |
Protein Kinase B/AKT and Focal Adhesion Kinase: Two Close Signaling Partners in Cancer |
(Eng)
|
|
Wang S., D. Basson M.
|
| Vol 11, No 1 (2011) |
Regulatory Cascades of Protein Phosphatases: Implications for Cancer Treatment |
(Eng)
|
|
Jailkhani N., K. Chaudhri V., V.S. Rao K.
|
| Vol 11, No 1 (2011) |
Dual-Specificity MAP Kinase Phosphatases as Targets of Cancer Treatment |
(Eng)
|
|
Nunes-Xavier C., Roma-Mateo C., Rios P., Tarrega C., Cejudo-Marin R., Tabernero L., Pulido R.
|
| Vol 11, No 1 (2011) |
Tumor-Derived Extracellular Fragments of Receptor Protein Tyrosine Phosphatases (RPTPs) as Cancer Molecular Diagnostic Tools |
(Eng)
|
|
E.L. Craig S., M. Brady-Kalnay S.
|
| Vol 11, No 1 (2011) |
High-Throughput Methods in Identification of Protein Tyrosine Phosphatase Inhibitors and Activators |
(Eng)
|
|
Mattila E., Ivaska J.
|
| Vol 11, No 10 (2011) |
TEM8 Targeted Cancer Therapy |
(Eng)
|
|
E. Frankel A., Carter C., Kuo S., Woo J., Mauldin J., Liu J.
|
| Vol 11, No 10 (2011) |
SMILES-based QSAR Approaches for Carcinogenicity and Anticancer Activity: Comparison of Correlation Weights for Identical SMILES Attributes |
(Eng)
|
|
A. Toropov A., P. Toropova A., Benfenati E., Gini G., Leszczynska D., Leszczynski J.
|
| Vol 11, No 10 (2011) |
Cancer Nanotechnology: Emerging Role of Gold Nanoconjugates |
(Eng)
|
|
A. Kudgus R., Bhattacharya R., Mukherjee P.
|
| Vol 11, No 10 (2011) |
Gold Nanostructures as Photothermal Therapy Agent for Cancer |
(Eng)
|
|
Choi J., Yang J., Jang E., Suh J., Huh Y., Lee K., Haam S.
|
| Vol 11, No 10 (2011) |
Strategies for the Biological Evaluation of Gold Anticancer Agents |
(Eng)
|
|
P. Fricker S.
|
| Vol 11, No 10 (2011) |
Protein Targets for Anticancer Gold Compounds: Mechanistic Inferences |
(Eng)
|
|
Gabbiani C., Messori L.
|
| Vol 11, No 10 (2011) |
Phosphine-Gold(I) Compounds as Anticancer Agents: General Description and Mechanisms of Action |
(Eng)
|
|
Carlos Lima J., Rodriguez L.
|
| Vol 11, No 10 (2011) |
Editorial [Hot Topic: Gold Derivatives as Anti-Cancer Agents (Guest Editor: Laura Rodriguez Raurell)] |
(Eng)
|
|
Rodriguez Raurell L.
|
| Vol 11, No 1 (2011) |
Metal-Based Inhibitors of Protein Tyrosine Phosphatases |
(Eng)
|
|
Lu L., Zhu M.
|
| Vol 11, No 1 (2011) |
Molecular Field Analysis (MFA) and Other QSAR Techniques in Development of Phosphatase Inhibitors |
(Eng)
|
|
C. Nair P.
|
| Vol 10, No 5 (2010) |
Compounds from Wild Mushrooms with Antitumor Potential |
(Eng)
|
|
C.F.R. Ferreira I., A. Vaz J., Vasconcelos M.H., Martins A.
|
| Vol 10, No 6 (2010) |
Editorial [Hot Topic: Emerging Therapeutic Targets and Agents for Glioblastoma Therapy Part I (Guest Editor: Hui-Wen Lo)] |
(Eng)
|
|
Lo H.
|
| Vol 10, No 6 (2010) |
Therapeutic Exploitation of Apoptosis and Autophagy for Glioblastoma |
(Eng)
|
|
Kogel D., Fulda S., Mittelbronn M.
|
| Vol 10, No 6 (2010) |
Exploiting Cyclooxygenase-(in)Dependent Properties of COX-2 Inhibitors for Malignant Glioma Therapy |
(Eng)
|
|
H. Schonthal A.
|
| Vol 10, No 6 (2010) |
Immunotherapy of Malignant Gliomas Using Autologous and Allogeneic Tissue Cells |
(Eng)
|
|
M. Hofman F., Stathopoulos A., A. Kruse C., C. Chen T., E.J.C. Schijns V.
|
| Vol 10, No 6 (2010) |
Mouse Induced Glioma-Initiating Cell Models and Therapeutic Targets |
(Eng)
|
|
Kondo T.
|
| Vol 10, No 6 (2010) |
Obesity Modulation - The Role in Carcinogenesis |
(Eng)
|
|
Legakis I., Syrigos K.
|
| Vol 10, No 6 (2010) |
Epidermal Growth Factor Receptor as a Target for Anti-Cancer Agent Design |
(Eng)
|
|
Cao J., Fang H., Wang B., Ma C., Xu W.
|
| Vol 10, No 6 (2010) |
Combination Therapy with Arsenic Trioxide for Hematological Malignancies |
(Eng)
|
|
Takahashi S.
|
| Vol 10, No 4 (2010) |
Latest Insights into the Anticancer Activity of Gold(III)-Dithiocarbamato Complexes |
(Eng)
|
|
Ronconi L., Aldinucci D., Ping Dou Q., Fregona D.
|
| Vol 10, No 5 (2010) |
Progresses in TCM Metal-Based Antitumour Agents |
(Eng)
|
|
Chen Z., Liang H.
|
| Vol 10, No 4 (2010) |
A Better Platinum-Based Anticancer Drug Yet to Come? |
(Eng)
|
|
Olszewski U., Hamilton G.
|
| Vol 10, No 4 (2010) |
Mechanisms of Cytotoxicity of Anticancer Titanocenes |
(Eng)
|
|
Olszewski U., Hamilton G.
|
| Vol 10, No 4 (2010) |
Proteomic and Metallomic Strategies for Understanding the Mode of Action of Anticancer Metallodrugs |
(Eng)
|
|
Gabbiani C., Magherini F., Modesti A., Messori L.
|
| Vol 10, No 4 (2010) |
Selenium in the Prevention and Treatment of Hepatocellular Carcinoma |
(Eng)
|
|
S. Darvesh A., Bishayee A.
|
| Vol 10, No 4 (2010) |
Boron-Containing Compounds as Preventive and Chemotherapeutic Agents for Cancer |
(Eng)
|
|
I. Scorei R., Popa R.
|
| Vol 10, No 5 (2010) |
Editorial [Hot topic: Metal-Containing Drugs and Novel Coordination Complexes in Therapeutic Anticancer Applications Part II (Guest Editor: Irena Kostova)] |
(Eng)
|
|
Kostova I.
|
| Vol 10, No 5 (2010) |
Enzyme Inhibition as a Key Target for the Development of Novel Metal-Based Anti-Cancer Therapeutics |
(Eng)
|
|
Griffith D., P. Parker J., J. Marmion C.
|
| Vol 10, No 5 (2010) |
Recent Researches in Metal Supramolecular Complexes as Anticancer Agents |
(Eng)
|
|
Zhou C., Zhang Y., Yan C., Wan K., Gan L., Shi Y.
|
| Vol 10, No 5 (2010) |
Fresh Platinum Complexes with Promising Antitumor Activity |
(Eng)
|
|
Wang X.
|
| Vol 10, No 7 (2010) |
Editorial [Hot topic: Emerging Therapeutic Targets and Agents for Glioblastoma Therapy Part II (Guest Editor: Hui-Wen Lo)] |
(Eng)
|
|
Lo H.
|
| Vol 10, No 7 (2010) |
STAT3 as a Therapeutic Target for Glioblastoma |
(Eng)
|
|
Liu Y., Li C., Lin J.
|
| Vol 10, No 8 (2010) |
Pomegranate Extract, A Prooxidant with Antiproliferative and Proapoptotic Activities Preferentially Towards Carcinoma Cells |
(Eng)
|
|
H. Weisburg J., G. Schuck A., S. Silverman M., G. Ovits-Levy C., J. Solodokin L., L. Zuckerbraun H., Babich H.
|
| Vol 10, No 8 (2010) |
Blockade of MUC1 Expression by Glycerol Guaiacolate Inhibits Proliferation of Human Breast Cancer Cells |
(Eng)
|
|
Baker C., Smith J., Colon J., Madero-Visbal R., Isley B., Konduri S.
|
| Vol 10, No 9 (2010) |
FK506 Binding Proteins as Targets in Anticancer Therapy |
(Eng)
|
|
Romano S., Di Pace A., Sorrentino A., Bisogni R., Sivero L., Fiammetta Romano M.
|
| Vol 10, No 9 (2010) |
Cell Biological Manifestations of Bisdioxopiperazines: Treatment of Human Tumor Cell Lines in Culture |
(Eng)
|
|
Lu D., Lu D., Ding J.
|
| 1001 - 1100 of 1156 Items |
<< < 1 2 3 4 5 6 7 8 9 10 11 12 > >>
|
